NR 566 FINAL EXAM PREP – ADVANCED PHARMACOLOGY – (2026) ACTUAL QUESTIONS AND ANSWERS
ALREADY GRADED A+| 100% VERIFIED SOLUTIONS
Core Domains
Pharmacokinetics and Pharmacodynamics
Infectious Disease Pharmacotherapy (Antibiotics, Antivirals, Antifungals)
Cardiovascular and Renal Pharmacology
Endocrine and Metabolic Pharmacology (Diabetes, Thyroid, Obesity)
Psychopharmacology and Neurologic Agents
Pain Management and Opioid Pharmacology
Pharmacotherapy for Special Populations (Geriatrics, Pediatrics, Pregnancy)
Hormone Therapy and Reproductive Health
Principles of Prescribing and Drug Safety
Ethical, Legal, and Regulatory Standards in Prescribing
Introduction
,This comprehensive examination is designed to assess mastery of the advanced pharmacological principles and
clinical decision-making skills required for the NR 566 Final Exam in Advanced Pharmacology for the Care of the
Family. The assessment evaluates knowledge across pharmacokinetics and pharmacodynamics, infectious disease
pharmacotherapy, cardiovascular and endocrine pharmacology, psychopharmacology, pain management, and
prescribing for special populations. Through a combination of multiple-choice questions and clinical scenario-
based items, candidates will demonstrate critical thinking, application of evidence-based guidelines, and the ability
to make safe and effective prescribing decisions in advanced practice nursing. Each question is accompanied by a
detailed rationale to reinforce learning and clarify key concepts.
SECTION ONE: QUESTIONS 1–100
1. A 72-year-old patient with hypoalbuminemia is prescribed a highly protein-bound medication. Which
pharmacokinetic change is the prescriber most concerned about?
A. Decreased volume of distribution
B. Increased free drug concentration and risk of toxicity
C. Decreased hepatic metabolism
D. Increased renal excretion
🟢 B. Increased free drug concentration and risk of toxicity
,🔴 RATIONALE: Hypoalbuminemia results in fewer protein-binding sites, leading to a higher free (unbound)
fraction of highly protein-bound drugs. This increases the pharmacological effect and risk of toxicity, as only the
free drug is pharmacologically active. Dosage adjustments may be necessary.
2. A patient with an intact uterus is prescribed systemic estrogen therapy for severe menopausal hot flashes.
What must be added to this regimen to prevent endometrial hyperplasia?
A. An androgen
B. A progestin
C. An additional estrogen dose
D. A selective estrogen receptor modulator (SERM)
🟢 B. A progestin
🔴 RATIONALE: In patients with an intact uterus, unopposed systemic estrogen therapy increases the risk of
endometrial hyperplasia and carcinoma. Adding a progestin counteracts this effect by promoting endometrial
shedding and reducing the mitogenic effect of estrogen on the endometrium.
3. A patient is diagnosed with uncomplicated cystitis. Which first-line antibiotic is most appropriate for a 7-
day course in a non-pregnant woman?
A. Ciprofloxacin
B. Nitrofurantoin
, C. Amoxicillin
D. Doxycycline
🟢 B. Nitrofurantoin
🔴 RATIONALE: Nitrofurantoin is a first-line agent for uncomplicated cystitis due to its high efficacy against
common uropathogens (E. coli) and low resistance rates. It is not recommended for pyelonephritis or in patients
with renal impairment (CrCl < 60 mL/min). Fluoroquinolones like ciprofloxacin are reserved for more
complicated infections due to resistance concerns.
4. A patient prescribed gentamicin for a severe infection develops tinnitus and dizziness. Which adverse
effect is the patient most likely experiencing?
A. Hepatotoxicity
B. Nephrotoxicity
C. Ototoxicity
D. Cardiotoxicity
🟢 C. Ototoxicity
🔴 RATIONALE: Gentamicin is an aminoglycoside antibiotic known for dose-related ototoxicity, which can
manifest as tinnitus, hearing loss, and vestibular dysfunction (dizziness, vertigo). Nephrotoxicity is another
serious adverse effect, but tinnitus and dizziness specifically indicate ototoxicity.
ALREADY GRADED A+| 100% VERIFIED SOLUTIONS
Core Domains
Pharmacokinetics and Pharmacodynamics
Infectious Disease Pharmacotherapy (Antibiotics, Antivirals, Antifungals)
Cardiovascular and Renal Pharmacology
Endocrine and Metabolic Pharmacology (Diabetes, Thyroid, Obesity)
Psychopharmacology and Neurologic Agents
Pain Management and Opioid Pharmacology
Pharmacotherapy for Special Populations (Geriatrics, Pediatrics, Pregnancy)
Hormone Therapy and Reproductive Health
Principles of Prescribing and Drug Safety
Ethical, Legal, and Regulatory Standards in Prescribing
Introduction
,This comprehensive examination is designed to assess mastery of the advanced pharmacological principles and
clinical decision-making skills required for the NR 566 Final Exam in Advanced Pharmacology for the Care of the
Family. The assessment evaluates knowledge across pharmacokinetics and pharmacodynamics, infectious disease
pharmacotherapy, cardiovascular and endocrine pharmacology, psychopharmacology, pain management, and
prescribing for special populations. Through a combination of multiple-choice questions and clinical scenario-
based items, candidates will demonstrate critical thinking, application of evidence-based guidelines, and the ability
to make safe and effective prescribing decisions in advanced practice nursing. Each question is accompanied by a
detailed rationale to reinforce learning and clarify key concepts.
SECTION ONE: QUESTIONS 1–100
1. A 72-year-old patient with hypoalbuminemia is prescribed a highly protein-bound medication. Which
pharmacokinetic change is the prescriber most concerned about?
A. Decreased volume of distribution
B. Increased free drug concentration and risk of toxicity
C. Decreased hepatic metabolism
D. Increased renal excretion
🟢 B. Increased free drug concentration and risk of toxicity
,🔴 RATIONALE: Hypoalbuminemia results in fewer protein-binding sites, leading to a higher free (unbound)
fraction of highly protein-bound drugs. This increases the pharmacological effect and risk of toxicity, as only the
free drug is pharmacologically active. Dosage adjustments may be necessary.
2. A patient with an intact uterus is prescribed systemic estrogen therapy for severe menopausal hot flashes.
What must be added to this regimen to prevent endometrial hyperplasia?
A. An androgen
B. A progestin
C. An additional estrogen dose
D. A selective estrogen receptor modulator (SERM)
🟢 B. A progestin
🔴 RATIONALE: In patients with an intact uterus, unopposed systemic estrogen therapy increases the risk of
endometrial hyperplasia and carcinoma. Adding a progestin counteracts this effect by promoting endometrial
shedding and reducing the mitogenic effect of estrogen on the endometrium.
3. A patient is diagnosed with uncomplicated cystitis. Which first-line antibiotic is most appropriate for a 7-
day course in a non-pregnant woman?
A. Ciprofloxacin
B. Nitrofurantoin
, C. Amoxicillin
D. Doxycycline
🟢 B. Nitrofurantoin
🔴 RATIONALE: Nitrofurantoin is a first-line agent for uncomplicated cystitis due to its high efficacy against
common uropathogens (E. coli) and low resistance rates. It is not recommended for pyelonephritis or in patients
with renal impairment (CrCl < 60 mL/min). Fluoroquinolones like ciprofloxacin are reserved for more
complicated infections due to resistance concerns.
4. A patient prescribed gentamicin for a severe infection develops tinnitus and dizziness. Which adverse
effect is the patient most likely experiencing?
A. Hepatotoxicity
B. Nephrotoxicity
C. Ototoxicity
D. Cardiotoxicity
🟢 C. Ototoxicity
🔴 RATIONALE: Gentamicin is an aminoglycoside antibiotic known for dose-related ototoxicity, which can
manifest as tinnitus, hearing loss, and vestibular dysfunction (dizziness, vertigo). Nephrotoxicity is another
serious adverse effect, but tinnitus and dizziness specifically indicate ototoxicity.
